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 13 
Abstract: A highly selective and sensitive liquid chromatography-tandem mass spectrometry 14 
method was developed and validated for the simultaneous identification and quantification of 15 
beta-casomorphin 5 (BCM5) and beta-casomorphin 7 (BCM7) in yoghurt. The method used 16 
deuterium labelled BCM5-d10 and BCM7-d10 as surrogate standards for confident 17 
identification and accurate and quantitation of these analytes in yoghurt.  Linear responses for 18 
BCM5 and BCM7 (R
2 
= 0.9985 and 0.9986, respectively) was observed in the range 0.01–10 19 
ng/µL. The method limits of detection (MLDs) in yoghurt extracts were found to be 0.5 ng/g 20 
and 0.25 ng/g for BCM5 and BCM7, respectively. Analyses of spiked samples were used to 21 
provide confirmation of accuracy and precision of the analytical method. Recoveries relative 22 
to the surrogate standards of these spikes were  in the range of 95 - 106 % for BCM5 and 103 23 
- 109% for BCM7.  Precision from analysis of spiked samples was expressed as relative 24 
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standard deviation (%RSD) and values were in the range 1-16% for BCM5 and 1-6% for 25 
BCM7.  Inter-day reproducibility was between 2.0-6.4% for BCM5 and between 3.2-6.1% 26 
for BCM7.  The validated isotope dilution LC-MS/MS method was used to measure BCM5 27 
and BCM7 in ten commercial and laboratory prepared samples of yoghurt and milk. Neither  28 
BCM5 and BCM7 were detected in commercial yoghurts. However, they were observed in 29 
milk and laboratory prepared yoghurts and interestingly their levels decreased during 30 
processing. BCM5 decreased from 1.3 ng/g in milk to 1.1 ng/g in yoghurt made from that 31 
milk at 0 day storage and < MLQ at 1 and 7 day storage. BCM7 decreased from 1.9 ng/g in 32 
milk to < MLQ in yoghurts immediately after processing. These preliminary results indicate 33 
that fermentation and storage reduced BCM5 and BCM7 concentration in yoghurt. 34 
 35 
1. Introduction 36 
Beta-casomorphins (BCMs) are a group of structurally similar peptides containing a sequence 37 
of 4-11 amino acids (Kamiński, Cieślińska, & Kostyra, 2007). The first three amino acids, 38 
tyrosine, proline and phenyalanine in the peptide, are conserved (Muehlenkamp & 39 
Warthesen, 1996) and arise from enzymatic hydrolysis of beta-caseins (β-CNs) (De Noni & 40 
Cattaneo, 2010). These peptides are released from the parent protein by cleavage at position 41 
60 (tyrosine), and a second cleavage of residues at positions 63 to 70. For example, a peptide 42 
with cleavages at position 60 (tyrosine) and position 66 (isoleucine) is beta-casomorphin 7 43 
(Fig. 1), which was first isolated from bovine casein (Brantl, Teschemacher, Henschen, & 44 
Lottspeich, 1979). BCMs have morphine-like activity, and therefore are classified as opioid 45 
peptides (Kamiński et al., 2007).  BCM5 and BCM7 (Fig. 1) have strong opioid activity 46 
(Brantl, Teschemacher, Bläsig, Henschen, & Lottspeich, 1981; Kálmán, Cserháti, Valkó, & 47 
Neubert, 1992; Kamiński et al., 2007). Epidemiological evidence suggests that consumption 48 
of milk containing A1 beta-casein, which releases BCM7 on hydrolysis, is linked to an 49 
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increased risk of type-1 diabetes and heart disease (Elliott, Harris, Hill, Bibby, & Wasmuth, 50 
1999; Laugesen & Elliott, 2003; McLachlan, 2001). However, the European Food Safety 51 
Authority (EFSA) concluded there were insufficient data to determine a causal relationship 52 
between exposure to BCM7 and other related BCMs and non-communicable diseases (EFSA, 53 
2009). Therefore, the reported presence of BCM5 and BCM7 in dairy products needs further 54 
research due to their putative link to elevated chronic disease risk.  55 
BCM7 is found in bovine milk (Cieślińska, Kaminski, Kostyyra, & Sienkiewicz-Szłapka, 56 
2007; Cieślińska et al., 2012), in human milk (Jarmołowska et al., 2007), in cheeses (De Noni 57 
& Cattaneo, 2010; Jarmolowska, Kostyra, Krawczuk, & Kostyra, 1999; Norris, Coker, 58 
Boland, & Hill, 2003; Sienkiewicz-Szłapka et al., 2009) and in commercial yoghurt 59 
(Jarmolowska, 2012). In contrast, De Noni & Cattaneo (2010) showed that BCM7 was not 60 
present in yoghurt purchased from a market. Therefore, the presence of BCM7 in yoghurt 61 
may be affected by processing steps in yoghurt manufacturing or levels may be below the 62 
limit of detection of previous analytical methods used.  63 
Yoghurt is a popular dairy product usually fermented by two lactic acid bacteria (LAB), 64 
Lactobacillus delbrueckii ssp. bulgaricus and Streptococcus thermophilus (Tamime & 65 
Robinson, 1999). In addition to containing angiotensin-converting enzyme inhibitory (ACE-66 
I) peptides (Donkor, Henriksson, Singh, Vasiljevic, & Shah, 2007; Kunda et al., 2012) , 67 
antihypertensive peptides (Kunda et al., 2012; Muguerza et al., 2006; Schieber & Brückner, 68 
2000), and antioxidant peptides (Sabeena Farvin, Baron, Nielsen, Otte, & Jacobsen, 2010), 69 
yoghurt may also contain BCM peptides (Jarmolowska, 2012). However, yoghurt is a 70 
complex food matrix (EFSA, 2009), in which protein, sugar or lactic acid can interfere with 71 
the identification and quantification of target analytes such as peptides.  72 
Reverse-phase high performance liquid chromatography (RP-HPLC) coupled to an 73 
ultraviolet-visible (UV-Vis) detector  is used widely for separation and quantification of 74 
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BCM5 and BCM7 in milk and dairy products (Jarmołowska et al., 2007; Muehlenkamp & 75 
Warthesen, 1996),. A limitation of RP-HPLC-UV for detection and quantification of BCMs 76 
is that peptides with similar physico-chemical and spectrophotometric absorption properties 77 
can co-elute with BCM5 and BCM7, increasing their apparent absorption values 78 
(Muehlenkamp & Warthesen, 1996; Sienkiewicz-Szłapka et al., 2009)resulting in an 79 
overestimation of BCM7  (Cass et al., 2008; Sienkiewicz-Szłapka et al., 2009) and BCM5 80 
concentration (Sienkiewicz-Szłapka et al., 2009). Additionally, analytical methods employing 81 
UV-Vis detector  may lack the sensitivity required to quantify the low levels (e.g. 2 µg/ml of 82 
cheese extract) of BCM7 and BCM5 found in dairy products (Muehlenkamp & Warthesen, 83 
1996).  84 
More recently, enzyme–linked immune sorbent assays (ELISA) have been applied to detect 85 
and quantify BCM5 and BCM7 in bovine milk and dairy products (Sienkiewicz-Szłapka et 86 
al., 2009; Cieślińska et al., 2012; Jarmolowska, 2012). ). However, during milk processing, 87 
heat treatment of milk may modify the conformation of BCM7 by interaction between lactose 88 
and amino acid residues, leading to a reduction in the binding affinity of the modified BCM7 89 
to the ELISA antibody, resulting in an underestimation of the BCM7 concentration 90 
(Cieślińska et al., 2012). RP-HPLC coupled with mass spectrometry (MS) represents “the-91 
state-of-the-art” method for identification and quantification of peptides in complex matrices. 92 
Cass et al. (2008) applied matrix-assisted laser desorption/ionisation-time of flight mass 93 
spectrometry (MALDI-TOF-MS) to analyse opioid-derived exogenous or endogenous 94 
peptides in urine, and found that peaks previously analysed by RP-HPLC-UV were 95 
erroneously identified as BCM7. Alternatively, tandem mass spectrometry (MS/MS) 96 
operating in multiple reaction monitoring (MRM) mode allows accurate quantification of 97 
BCM7 in plasma at low levels (ng/ml) (Song, Zaw, Amirkhani, Clarke, & Molloy, 2012). 98 
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Currently, there is no report in the literature on LC-MS/MS applications for the simultaneous 99 
quantification of BCM5 and BCM7 in different processing stages of yoghurt manufacture.  100 
The choice of calibration method plays an important role in LC-MS quantitative analysis. 101 
External calibration using standards can be used. However, this approach could result in ion 102 
suppression, leading to a decrease in the response of target analytes (Jessome & Volmer, 103 
2006). In addition, using external standards requires that calibration samples are identical in 104 
composition to test samples, to compensate fully for matrix effects (Jessome & Volmer, 105 
2006). To date, the use of UHT milk extract for dissolving synthesised BCM5 and BCM7 as 106 
calibration samples has been reported by De Noni and Cattaneo (2010) who used LC-MS/MS 107 
coupled to electrospray ionization (ESI) for quantifying BCM5 and BCM7 in yoghurt. The 108 
extracts of UHT milk, however, are not identical to those of yoghurt because after 109 
fermentation, many compounds in milk are degraded into different ones in yoghurt, for 110 
instance, lactose is degraded into lactic acid.  Therefore, the difference in matrix may affect 111 
ion suppression, leading to variable results.  112 
Inclusion of deuterated homologues in LC-MS/MS quantitative analysis is an alternative 113 
technique that allows easy identification and quantification of target analytes in complex 114 
matrices. Stable isotope-labelled compounds allow compensation for matrix effects and loss 115 
of target analytes during sample preparation, so their use can significantly reduce data 116 
variability and improve accuracy and precision of the analytical determination (Jessome & 117 
Volmer, 2006). Recently, Song et al. (2012) used LC-MS/MS and applied stable isotope-118 
labelled BCM7 as the surrogate standard for quantitation of BCM7 in plasma at low 119 
concentrations (ng/ml). To date, however, there are no reported studies using stable isotope-120 
labelled BCM7 and BCM5 as the surrogate standards for simultaneous determination of these 121 
peptides in yoghurt.       122 
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The aim of this study was to develop a sensitive and selective method for the accurate 123 
determination of BCM5 and BCM7 in yoghurt. For separation and detection, the method 124 
employed LC coupled to MS/MS operated in MRM mode. Stable isotope-labelled BCM5 and 125 
BCM7 were used as surrogate standards for confident identification and accurate and 126 
quantitation purposes. The LC-MS/MS method was also tested for the identification and 127 
quantitation of target BCMs in commercial and laboratory prepared yoghurts.   128 
 129 
2. Materials and methods 130 
2.1 Chemicals and materials 131 
Yoghurt culture (YO-MIX
TM
) containing Streptococcus thermophilus and Lactobacillus 132 
delbrueckii ssp. bulgaricus was purchased from Danisco Australia Pty Ltd (Botany, NSW, 133 
Australia). UHT milk and A1 skim milk powder were supplied by A2 Dairy Products 134 
Australia Pty Ltd (Botany, NSW, Australia). BCM5 (purity 97.8%), BCM7 (purity >98.7%) 135 
and the deuterated standards [
2
H10] BCM5 (BCM5-d10) and [
2
H10] BCM7 (BCM7-d10) - 136 
deuterium enrichment > 99%, 
2
H enrichment at phenylalanine position - were obtained from 137 
Auspep Pty (Tullamarine, Victoria, Australia). Ultrapure water used for laboratory purposes 138 
as well as LC mobile phase was purified using an IBIS Technology (Perth, Australia) Ion 139 
Exchange System followed by Elga Purelab Ultra System (Sydney, Australia). Methanol 140 
(ChromAR HPLC grade) was purchased from Mallinckrodt (New Jersey, USA); formic acid 141 
(purity 99%) was purchased from Ajax FineChem (Sydney, Australia).  142 
2.2 Solutions and calibration standards 143 
Stock solutions of analytes of BCM5, BCM7 and deuterated standards BCM5-d10, BCM7-d10 144 
were prepared by dissolving 5 mg of each compound in a 5 ml flask of ultrapure water 145 
(nominal concentration of 1 mg/ml). Working stock solutions (10 ng/µL and 25 ng/µL) were 146 
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prepared by diluting stock solutions in ultrapure water. Serial mixed standard solutions of 147 
BCM5 and BCM7 ranging from 0.01 to 25 ng/μL (nominal concentrations 0.01, 0.025, 0.05, 148 
0.1, 0.25, 0.75, 1, 2.5, 5, 7.5, 10, 12.5 and 25 ng/μL) were prepared from the working stock 149 
solutions. A working solution (nominal concentration of 10 ng/µL) of deuterated standards 150 
was also prepared by dilution of BCM5-d10 and BCM7-d10 stock solutions.  All the solutions, 151 
as well as analytical and surrogate standards were stored at –20 ºC to minimise degradation. 152 
2.3 Laboratory-prepared yoghurts 153 
Yoghurt was prepared by inoculating YO-MIX
TM 
into the UHT milk preheated at 43 
0
C in an 154 
incubator. The inoculated milk was then incubated at 43 
0
C until pH 4.6 was reached. After 155 
fermentation, yoghurt was cooled down and stored at 4 
0
C. This product was used for 156 
validation of analytical method and is referred to as “laboratory prepared yoghurt”. In order 157 
to prepare yoghurt for the application of analytical method, 65 grams of A1 skim milk 158 
powder was dissolved in 0.5 litre of deionised water that was pre-boiled for 10 minutes and 159 
then cooled down to 55 
0
C. After thorough mixing, 100 ml of reconstituted milk was placed 160 
into two tightly capped centrifuge tubes and stored at -20 
0
C prior to analysis. The rest of the 161 
reconstituted milk was cooled down to 43 
0
C and inoculated with 0.003% (w/v) of YO-162 
MIX
TM
. The inoculated milk was placed into seven centrifuge tubes, which were then capped, 163 
and fermented at 43
0
C until the pH reached the value of 4.6. One tube was used to measure 164 
pH during the course of fermentation. When pH reached the required value, two tubes were 165 
stored -20
 0
C for further analysis. Two tubes were stored for 1 day and two others were stored 166 
for 7 days at 4 
0
C. All these tubes were stored -20
 0
C until extraction of water soluble 167 
peptides. 168 
2.4 Extraction of water soluble peptides 169 
The preparation of yoghurt extracts was carried out as described in Donkor et al. (2007) with 170 
some minor modifications. Ten grams of yoghurt were weighted (± 0. 1g) into a centrifuge 171 
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tube, then centrifuged at 15,000×g at 4 
0
C for 30 min. The supernatant was decanted into a 172 
clean centrifuge tube and the extract was adjusted to pH 4.6 with 1M HCl (or 1M NaOH). 173 
After re-centrifugation at 14,000×g for 20 min at 4 
0
C, the supernatant was collected by 174 
decantation and filtered through a 0.45 µm membrane filter. The filtered extract was 175 
evaporated to a final volume of 1 mL using a gentle nitrogen flow over the extract surface. 176 
The concentrated extract was filtered through a 0.45 µm membrane filter into a vial. 177 
2.5 Liquid chromatography-tandem mass spectrometry conditions  178 
The LC-MS/MS system used in this study consisted of an 1100 Agilent (Palo Alto, CA, 179 
USA) LC system and a Micromass (Manchester, UK) Quattro Ultima Triple Quadrupole 180 
Mass spectrometer fitted with an electrospray ion source (ESI) operated in positive ionisation 181 
mode. Chromatographic separation was achieved using a Kinetex C18 LC-MS column (100 182 
mm × 2.1 mm, 2.6 μm, 100 Å) from Phenomenex (Sydney, Australia) at a flow rate of 100 183 
μL/min. A KrudKatcher Ultra HPLC in-line filter (0.5 µm depth filter x 0.004 inch ID) was 184 
used to protect the analytical column. The mobile phase was methanol (MeOH) (A) and 185 
ultrapure water (B) both containing 0.1% of formic acid. Chromatographic runs began with 186 
30% (A) for 3 min, followed by a 15 min linear gradient to 100% (A). The mobile phase 187 
remained at 100% (A) for 15 min to elute analytes from the column. Afterwards, the initial 188 
conditions were re-established within 1 min and the column re-equilibrated for 15 min before 189 
injecting the next sample. To minimise potential carryover, before and after each injection, 190 
the needle of the injector was rinsed for 30 seconds in the injection port with MeOH. The 191 
injected volume was 5 μL. 192 
Optimum MS signals were achieved by tuning the ESI capillary and cone voltages to 3.25 193 
KV and 25 V, respectively. Hexapole1, aperture and hexapole2 were set to 0.0 V, 0.1 V and 194 
0.2 V, respectively. Desolvation temperature and source temperature were 325 ºC and 135 ºC, 195 
respectively. Cryogenic liquid nitrogen gas (BOC Gases, Perth, Australia) was used as 196 
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desolvation and nebulizer gas; cone gas flow was set to 40 L/h, while the desolvation gas 197 
flow was set to 765 L/h. High purity Argon (99.997% purity) (BOC Gases, Perth, Australia) 198 
was used as collision gas (P = 2.7 × 10
-4
 kPa). Both quadrupoles (Q1 and Q3) were set at unit 199 
mass resolution; ion energy on Q1 and Q3 was set to 1.0, while the multiplier was set at 750 200 
V. Surrogate standards, BCM5-d10 and BCM7-d10 were included in the analytical method to 201 
correct results for any losses encountered during sample extraction and to correct for matrix 202 
effects (Jessome & Volmer, 2006). Quantification was performed by rationing the peak area 203 
of the analytes to the peak area of the corresponding deuterated standards. Concentrations 204 
were calculated by QuanLynx 4.0 software comparing the peak area ratios from the extracts 205 
to peak area ratios from the calibration standards.  206 
2.6 Validation of the analytical method 207 
Evaluation of instrumental linearity, instrumental detection limits (IDLs) instrumental 208 
quantification limits  (IQLs), peak identification criteria (retention time and MRM ratio), 209 
accuracy, precision, inter-day reproducibility, method limits of detection (MLDs), method 210 
limits of quantitation (MLQs), and matrix effects were undertaken to validate the analytical 211 
procedure. 212 
2.6.1 LC-MS/MS performance 213 
Repetitive injections of standard solutions were used to assess LC-MS/MS instrument 214 
performance. The linear range was tested using calibration standards spanning from 0.01 215 
ng/μL up to 25 ng/μL.  Injections of low concentrations standard solutions were used to 216 
assess IDLs and IQLs. IDLs were estimated at signal-to-noise (S/N) ratio equal to 3 while 217 
IQLs were estimated at S/N=10. Repeat injections (n=15) of a solution at 1 ng/μL were used 218 
to determine the variability of the MRM ratio and of the retention time. 219 
2.6.2 Accuracy and precision 220 
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Accuracy and precision of the analytical method were assessed by recovery experiments of 221 
BCMs in yoghurt. Yoghurt samples (10 g) were spiked with standard solutions of BCM5 and 222 
BCM7 at five different levels of concentration (1, 10, 100, 1000 and 2500 ng/g) in triplicate. 223 
Surrogate standards were also spiked at a concentration level of 100 ng/g.  Accuracy was 224 
expressed as recovery relative to the surrogate standards, while precision was expressed as 225 
relative standard deviation (%RSD). Blank samples (10 g of yoghurt spiked with 100 ng/g of 226 
deuterated standards) were also processed in triplicate along with each batch of samples for 227 
QA/QC purposes. 228 
2.6.3 Inter-day reproducibility 229 
Repeated measurements on two different days of three yoghurt samples spiked with 10, 100 230 
and 1000 ng/g of BCM5 and BCM7 were conducted. The %RSD of these measurements was 231 
used to assess the inter-day reproducibility of the analytical method.  232 
2.6.4 Method limit of detection and method limit of quantitation 233 
Yogurt samples spiked with low levels of BCM5 and BCM7 (1 ng/g and 10 ng/g) were 234 
extracted and analysed; the results were used to estimate MLDs and MLQs. MLDs were 235 
calculated from the concentration equivalent to S/N of three, while MLQs were calculated 236 
from the concentration equivalent to S/N of ten (Busetti, Linge, Blythe, & Heitz, 2008; Foley 237 
& Dorsey, 1984) on smoothed chromatographic traces.  238 
2.6.5 Evaluation of matrix effects  239 
In order to study the degree of signal suppression caused by the presence of the matrix, blank 240 
yoghurt extracts were spiked at 1000 ng/mL with BCM5 and BCM7 and analysed by LC-241 
MS/MS. Results were compared to injections of analytical standards at the same 242 
concentration levels. Matrix effects were calculated as followed (Eq. 1): 243 
Matrix effects (%) = (As-Am)/As X 100 (1) 244 
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Where: As is the area of the analyte spiked in ultrapure water (standard solution) and Am is 245 
the area of the analyte spiked in a yoghurt blank extract (matrix). 246 
2.7 Analysis of commercial and laboratory prepared samples of yoghurt and reconstituted 247 
milk  248 
Ten commercial yoghurts were purchased from a local supermarket located in Perth, Western 249 
Australia. Three yoghurts contained S. thermophilus and L.  delbrueckii ssp. bulgaricus, other  250 
yoghurts contain S. thermophilus, L. delbrueckii ssp. bulgaricus, L. acidophilus and 251 
Bifidobacterium  or contain L. acidophilus, Bifidobacterium and L. casei. The expiry dates of 252 
all yoghurts ranged from 13 and 29 days. The samples were extracted immediately after 253 
purchasing.  254 
Commercial and laboratory prepared yoghurts and reconstituted milk samples were prepared 255 
as described in Section 2.4. The laboratory prepared yoghurts and reconstituted milk were 256 
thawed at room temperature and thoroughly mixed before sampling. Ten grams of 257 
reconstituted milk was gradually acidified with 1M HCl to pH 4.6 and allowed to rest for 10 258 
minutes. Before extraction, yoghurt and reconstituted milk samples were spiked with 259 
surrogate standards BCM5-d10 and BCM7-d10 at a concentration level of 100 ng/g. In 260 
addition, 10 g of yoghurt and 10 g of reconstituted milk spiked with both 1000 ng of BCM5-261 
d10 and 1000 ng of BCM7-d10 as well as 100 ng of BCM5 and 100 ng of BCM7 were used as 262 
quality control samples (QCs). The QCs were extracted as described in Section 2.4. BCM5 263 
and BCM7 were analysed using the validated LC-MS/MS method as described in Section 264 
2.5. All samples were extracted and analysed in duplicate.  265 
 266 
3. Results and discussions 267 
3.1 Optimisation of MS/MS conditions 268 
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Solutions consisting of BCM5 and BCM7 at 5 ng/µL in MeOH:H2O (50:50) with 0.1% of 269 
formic acid were infused into the mass spectrometer to optimise: 1) formation of protonated 270 
parent ions minimising secondary adducts; 2) fragmentation of selected parent ions (MS/MS) 271 
and 3) detection of product ions in MRM mode.  272 
Initial experiments were conducted in MS scan mode (50-1000 m/z). In the presence of 0.1% 273 
of formic acid, the most intense precursor ion observed for BCM5 and BCM7 was the proton 274 
adduct [M+H]
+
; other characteristic ESI precursor ions such as the sodium or MeOH adducts 275 
usually present in non-acidic/methanolic solutions were substantially weaker. The [M+H]
+
 276 
precursor ions were therefore selected for further MS/MS experiments. Fragmentation 277 
experiments were conducted in product ion scan mode. While the MS/MS spectra of BCM7 278 
have been reported previously (De Noni, 2008), the fragmentation spectrum of BCM5 is 279 
reported in Fig. 2 along with assignment of the main product ions observed.  280 
After optimisation of  the collision energy, which controls the degree of fragmentation of the 281 
parent compound in the collision cell (Q2), the most intense characteristic transitions were 282 
identified from the product ion spectra (data not shown). Two MRM transitions (one parent 283 
ion fragmenting into two product ions) were used for the identification of each compound and 284 
surrogate standard (Table 1). This approach provides four identification points, which are 285 
sufficient to fulfil the criteria for identifying and confirming the presence of a target analyte 286 
in food matrices (EC, 2002). In addition, the MRM ratio and retention time (tR) were also 287 
monitored against standard solutions for additional confidence. 288 
3.2 Instrumental performance and peaks identification criteria 289 
Injections of standard solutions were used to assess LC-MS/MS instrument performance. An 290 
example of a LC-MS/MS chromatogram of a 1 ng/µL standard solution of BCM5, BCM5-291 
d10, BCM7 and BCM7-d10 is showed in Fig. 3. 292 
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The linear range was tested using calibration standards spanning from 0.01 ng/μL (0.05 ng 293 
on-column) to 25 ng/μL (125 ng on-column).  For both BCM5 and BCM7 tested, calibration 294 
curves showed good linearity in the range 0.05-50 ng on-column, with R
2
 values typically 295 
higher than 0.9985 (Table 2). Injections of low concentrations standard solutions were used 296 
to assess IDLs and IQLs. IDLs for BCM7 and BCM5, estimated at S/N ratio equal to 3, 297 
ranged from 0.007 to 0.010 ng on-column, respectively. For BCM7 and BCM5, IQLs were 298 
estimated at S/N=10, and ranged from 0.024 to 0.036 ng on-column, respectively. Repeat 299 
injections (n=15) of a solution at 1 ng/μL were used to determine the variability of the MRM 300 
ratio and of the retention time. MRM ratio variability, measured as %RSD, was less than 301 
8.8% indicating reproducible fragmentation of the parent ions in the collision cell; tR 302 
variability, measured as standard deviation (SD) was  less than 12 seconds, indicating a 303 
reproducible chromatographic separation.  304 
3.3 Accuracy and precision 305 
Accuracy and precision of the analytical method were determined by experiments on yoghurt 306 
samples spiked with increasing concentration of BCM5 and BCM7. Accuracy was expressed 307 
as recovery percentage relative to the surrogate standards while precision was expressed as 308 
%RSD. Accuracy was in the range 95 - 106 % for BCM5 and 103 - 109% for BCM7 (Table 309 
3). Relative standard deviation of these recoveries was between 1-6% for BCM7, and 1-7% 310 
for BCM5 exception for the value at spiked concentration of 1 ng/g (%RSD = 16) (Table 3). 311 
No corrections to recovery were necessary since blank samples were found not to contain 312 
BCM5 and BCM7 in detectable amounts. 313 
3.4 Inter-day reproducibility 314 
The inter-day reproducibility of the LC-MS/MS analytical method was determined by 315 
repeated measurements on two different days of three yoghurt samples spiked with different 316 
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amount of BCM5 and BCM7 (Table 3). Relative standard deviation values were 6.4% and 317 
6.1% for BCM5 and BCM7 respectively; indicating good reproducibility of the method.  318 
3.5 Method limits of detection (MLDs) and method limits of quantitation (MLQs) 319 
Average sample based MLDs and MLQs in yoghurt extracts were calculated from analysis of 320 
samples spiked with 1 ng/g and 10 ng/g of BCM5 and BCM7. MLDs were found to be 0.5 321 
ng/g for BCM5 and 0.25 ng/g for BCM7. Meanwhile, MLQs for BCM5 and BCM7 were 322 
found to be 1.7 ng/g and 0.85 ng/g, respectively. These results are difficult to compare with 323 
published methods because, to the best of our knowledge, MLDs and MLQs for BCM5 and 324 
BCM7 in yoghurt have not been reported previously (Nguyen, Johnson, Busetti, & Solah, 325 
2013). 326 
3.6 Evaluation of matrix effects affecting detection of BCM5 and BCM7 in yoghurt 327 
The efficiency of ESI sources to ionise polarisable analytes in real samples, is often affected 328 
by the matrix, which can be responsible for suppressing the absolute response of analytes 329 
when analysed in LC-MS/MS. If no corrections are made, matrix effects often lead to an 330 
underestimation in the concentration of the analytes of interest in real samples. In order to 331 
address matrix effects, different approaches have been proposed (Jessome & Volmer, 2006). 332 
For example, De Noni and Cattaneo, (2010) reported the use of matrix matched calibration 333 
standards to take into account the presence of the matrix when quantifying BCM7 in UHT 334 
milk. This is a valid and effective method to account for matrix effects especially when 335 
deuterated standards are unavailable or prohibitively expensive.  336 
In the present work, matrix effects were corrected for with the inclusion of deuterated 337 
homologues. This approach is by far the most effective method to account for matrix effects 338 
as the analytes and the corresponding co-eluting deuterated homologues are theoretically 339 
subject to identical matrix effects. In order to study the degree of signal suppression caused 340 
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by the presence of the matrix, blank yoghurt extracts were spiked at 1000 ng/mL with BCM5 341 
and BCM7 and analysed by LC-MS/MS. Results were compared to injected analytical 342 
standards at the same concentration levels. Matrix effects were responsible for causing about 343 
26% signal suppression for BCM5 and about 40% signal suppression for BCM7. It is 344 
possible that additional clean up (e.g. on-line or off-line solid-phase extraction) for sample 345 
matrix would decrease observed signal suppression, which could improve detection limits.   346 
3.7 Application of the validated method 347 
The validated method was applied to the identification and quantification of BCM5 and 348 
BCM7 in ten commercial yoghurts, laboratory prepared yoghurt and reconstituted milk. 349 
Neither BCM5 nor BCM7 was detected in commercial products, however both peptides were 350 
identified and quantified in reconstituted milk and laboratory prepared yoghurts. The content 351 
of BCM5 decreased from 1.3 ng/g in milk to 1.1 ng/g in yoghurt at 0 day storage and to less 352 
than the MLQ at 1 and 7 day storage. BCM7 content decreased from 1.9 ng/g in milk to less 353 
than the MLQ in yoghurts at all storage days (Table 5). It appears, BCM5 and BCM7 present 354 
in the milk have degraded into small peptides during fermentation and storage of yoghurt. 355 
Recently, there have been a few studies measuring BCM5 and BCM7 in commercial 356 
yoghurts. De Noni and Cattaneo (2010) attempted to measure both peptides in these products, 357 
but neither BCM5 nor BCM7 was found. Nevertheless, BCM7 has been quantified between 358 
0.86 to 2.45 µg/g in natural and probiotic yoghurt, levels decrease considerably during 359 
storage (Jarmolowska, 2012).  360 
Kunda et al. (2012) have identified several di-peptides such as β-CN fragment 60-61 and β-361 
CN fragment 62-63 in commercial yoghurt. As can been seen in Fig.1, amino acids at 362 
position 61 and 63 on the chain of parent β-CNs are proline residues. This finding shows that 363 
yoghurt bacterial enzymes are likely to digest the peptide bonds between proline and other 364 
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amino acid residues, leading to degradation of BCM5 and BCM7 during storage. The 365 
degradation of these peptides during yoghurt processing may involve the activity of X-prolyl 366 
dipeptidyl aminopeptidase (PepX), which is an enzyme derived from LAB that specifically 367 
hydrolyses peptide bonds between proline and other residues (Gobbetti, 2002). Furthermore, 368 
PepX activity in dairy products fermented with LAB has demonstrated to increase during 369 
storage (Otte, Lenhard, Flambard & Sørensen, 2011).  370 
 371 
4. Conclusions 372 
A highly selective and sensitive analytical method employing LC-MS/MS was successfully 373 
developed and validated for the simultaneous determination of BCM5 and BCM7 in a 374 
complex matrix, yoghurt. For the highest confidence in the identification and quantification 375 
of BCM5 and BCM7, two isotopically labelled homologues were included in the method as 376 
surrogate standards. The method showed very low MLQs, (1.7 ng/g for BCM5 and 0.85ng/g 377 
for BCM7)making it suitable for the analysis of the low level of BCMs  in yoghurt .  378 
This validated method was applied to analyse BCMs in commercial and laboratory prepared 379 
yoghurts and in milk. The absence of BCM5 and BCM7 in commercial yoghurts tested may 380 
have been due to degradation of these peptides during processing or storage. In the laboratory 381 
prepared yoghurt and milk tested, fermentation and storage lowered the content of BCM5 and 382 
BCM7.   383 
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Table 1. Mass spectrometry: precursor ions, product ions and collision energy values 487 
optimised for the analysis of BCM5 and BCM7 under ESI(+) MS/MS in Multiple Reaction 488 
Monitoring (MRM) mode. MRM transitions were grouped in one window. Dwell time was 489 






































Table 2. Instrument performance parameters obtained by repeat injections of standard 499 








S/N = 3 
IQL
a,c 





BCM-5 0.05–50 0.9985 0.010 0.036 3.0±7.8 18.2±0.2 
BCM-7 0.05–50 0.9986 0.007 0.024 2.6±8.8 20.6±0.1 
ang on-column; b IDL: Instrumental Detection Limit; c IQL: Instrumental Quantitation Limit; MRM: Multiple 501 
































BCM5 1 106 16 
10 104 7 
100 106 2 
1000 95 2 
2500 97 1 
BCM7 1 103 5  
10 109 4 
100 107 6 
1000 106 1 










Table 4. Inter-day reproducibility data determined by repeat measurements on two different 524 


















BCM5 10 10.4 11.2 10.8 6.4 
100 106 106 106 2.0 
1000 950 1000 974 3.6 
BCM7 
 
10 10.7 11 10.8 6.1 
100 110 111 110 3.4 













Table 5. BCM5 and BCM7 concentrations in reconstituted milk and laboratory prepared 536 
yoghurts. Results for Quality Control (QC) samples are also reported. 537 









Yogurt, 0 day storage 1.1
a
 <MLQ 
Yoghurt, 1 day storage <MLQ <MLQ 
Yoghurt, 7 day storage  <MLQ <MLQ 










amean values, n=2; brecoveries (%) are the average ± RSD% of n=2 milk samples spiked at 100 ng/mL; c 538 



















Fig. 1. Structure of BCM5 (A) and BCM7 (B) (adapted from Juan-García, Font, Juan, & 556 
















Fig. 2. Product ions spectrum showing the fragmentation of BCM5 obtained at variable 571 
collision energy values. The amino acids tyrosine (Tyr), proline (Pro), phenylalanine (Phe), 572 










Fig. 3. Typical LC-MS/MS chromatograms of BCM5 and BCM7 and their corresponding 581 
deuterated homologues BCM5-d10 and BCM7-d10. The ion source was an ESI operated in 582 
positive ion mode, while the mass spectrometer was a triple quadrupole operated in MRM 583 
mode. 584 
 585 
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 587 
